Clinical Trials Logo

Clinical Trial Summary

Brimonidine tartrate is an alpha-2 agonist ocular hypotensive drug that exerts its effect by causing both a decrease in aqueous production and an increase in uveoscleral outflow. It has been proven to reduce increased intraocular pressure in glaucoma and ocular hypertension. As an alpha 2 agonist Brimonidine belongs to the same class of drugs as Clonidine; however, its molecular structure is sufficiently different to make it more selective for the alpha 2 receptor than Clonidine. Unlike Clonidine, Brimonidine does not appear to have an effect on the central nervous system and therefore does not cause sedation or systemic hypotension.

In addition to their known effect of lowering intraocular pressure, alpha 2 adrenoceptor agonists are neuroprotective. It has, however, been shown that Brimonidine is a very potent vasoconstrictor in the ciliary body thus reducing aqueous humor production. Little is, however, known about potential vasoconstrictor effects of Brimonidine in the posterior pole of the eye. This is of clinical importance, because optic nerve head ischemia appears to contribute to glaucoma pathophysiology.

This study is performed to investigate the effects of topical Clonidine vs. topical Brimonidine on choroidal blood flow and intraocular pressure during isometric exercise.


Clinical Trial Description

n/a


Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double-Blind, Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT00312416
Study type Interventional
Source Medical University of Vienna
Contact
Status Completed
Phase Phase 4
Start date February 2004
Completion date December 2004

See also
  Status Clinical Trial Phase
Completed NCT01734616 - Dysfunction of Nutritive Blood Flow as a Determinant of Anabolic Resistance in Older People N/A
Completed NCT00431691 - Effect of Antioxidants on Ocular Blood Flow, Endothelial Function, and Cytokine Levels in LPS Induced Inflammatory Model in Humans. Phase 4
Completed NCT00810927 - Role of Nitrogen Oxide (NO) in the Control of Choroidal Blood Flow During a Decrease in Ocular Perfusion Pressure Phase 2
Completed NCT00431392 - Mechanisms of Choroidal Blood Flow Changes During Dark/Light Transitions Phase 2
Completed NCT00540215 - GLP-2 (Glucagonlike Peptide-2) and Blood Flow N/A
Completed NCT02589054 - Regional Changes in Upper Limb Perfusion Following Brachial Plexus Block: A Pilot Study N/A
Completed NCT00707226 - Circadian Variations in Ocular Blood Flow in Glaucomatous and Normal Eyes N/A
Completed NCT00709449 - An Open Study Comparing the Effects of Moxaverine on Ocular Blood Flow in Patients With Age- Related Macular Degeneration, Primary Open Angle Glaucoma and Healthy Control Subjects Phase 2/Phase 3
Terminated NCT00708357 - Does eNOS Gene Polymorphism Play a Role in the Maintenance of Basal Vascular Tone in the Choroid or Optic Nerve Head? Phase 0
Terminated NCT00709657 - The Effect of a Single Intravitreal Anti-VEGF Therapy on Optic Nerve Head Perfusion N/A
Completed NCT00709423 - Effects of Moxaverine and Placebo on Ocular Blood Flow Phase 2
Completed NCT00814008 - The Relationship Between Stage of Diabetic Retinopathy and Retinal Blood Flow in Patients With IDDM During Euglycemic Clamp Phase 2
Completed NCT00708929 - Does Complement Factor H Gene Polymorphism Play a Role in the Regulation of Vascular Tone in the Choroid? N/A
Completed NCT00712400 - Effects of Latanoprost on Choroidal Blood Flow Regulation in Human Subjects N/A
Completed NCT00312325 - Effect of High-Dose Prednisolone (Solu Dacortin®) Treatment on Choroidal and Optic Nerve Head Blood Flow in Humans Phase 4
Withdrawn NCT00312390 - Amblyopia and Neurovascular Coupling in the Retina of Humans N/A
Withdrawn NCT00406731 - Role of Endothelin- and Nitric Oxide-system in the Regulation of Optic Nerve Head Blood Flow During Changes in Ocular Perfusion Pressure Phase 2
Completed NCT00275730 - Effects of Indomethacin on Retinal and Choroidal Blood Flow in Healthy Volunteers N/A
Completed NCT00712907 - Effects of Vitamin C on Hyperoxia-Induced Reduction of Retinal Blood Flow N/A
Withdrawn NCT02978560 - Indocyanine Green Tissue Perfusion Monitoring